Pfizer Camptosar Sales Aid Cited By FDA For Minimizing Diarrhea Risk

FDA is citing a visual aid used by Pfizer sales reps for minimizing the risks of diarrhea associated with the cancer product Camptosar (irinotecan)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Pink Sheet